Application of Al18F-NOTA-LM3 PET/CT in the Diagnosis and Evaluation of Tumor-Induced Osteomalacia
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This is a pilot study to assess the value of whole-body Al18F-NOTA-LM3 PET/CT in patients with tumor-induced osteomalacia.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:
• Patients aged 18 to 80 years.
• Suspected or confirmed TIO patients.
Locations
Other Locations
China
Peking Union Medical College Hospital
RECRUITING
Beijing
Contact Information
Primary
Hongli Jing
annsmile1976@sina.com
18600586399
Backup
Yuwei Zhang
ywzhangwork@163.com
18511071577
Time Frame
Start Date: 2023-03-30
Estimated Completion Date: 2026-05-30
Participants
Target number of participants: 40
Treatments
Experimental: Al18F-NOTA-LM3 and 68Ga-DOTATATE PET/CT scan
Patients of TIO PET/CT imaging: Patients will perform an Al18F-NOTA-LM3 PET/CT as well as a 68Ga-DOTATATE PET/CT.
Related Therapeutic Areas
Sponsors
Leads: Peking Union Medical College Hospital